Tau pathologyP-tau (181)

Apolipoprotein EPhenotype: ApoE 4, pan-ApoE

Genotype: ApoE ε2, ε3, ε4

Amyloid pathologyA (1-42)A (1-40)A (1-38)

Neuronal degenerationTotal-tau

P-neurofilament H

Pre-/post-synapticNeurogranin (trunc P75)

BACE1

EUROIMMUN AG · D-23560 Luebeck (Germany) · Seekamp 31 · Tel +49 451 58550 · Fax 5855591 · E-mail euroimmun@euroimmun.de

Biomarkers for neurodegeneration

EUROIMMUN

Automatable

Quality control samples for all tests

Aligned protocols

Fully validated

Biomarkers for synaptic integrity

Biomarkers for brain pathology

Risk factors for neurodegenerative diseases

EUROIMMUN AG · D-23560 Luebeck (Germany) · Seekamp 31 · Tel +49 451 58550 · Fax 5855591 · E-mail euroimmun@euroimmun.de

Available product Description CSF Plasma Order no.

Beta-Amyloid (1-38) ELISATest kit for the quantitative determination of beta- amyloid (1-38) as an additional diagnostic tool in suspected clinical amyloid pathology of the brain.

EQ 6501-9601-LEQ 6501-9601

Beta-Amyloid (1-40) ELISA

Test kit for the quantitative determination of beta- amyloid (1-40). Can be used to calculate beta-amyloid (1-42)/beta-amyloid (1-40) as an additional diagnostic tool in suspected amyloid pathology of the brain.

EQ 6511-9601-LEQ 6511-9601

Beta-Amyloid (1-42) ELISATest kit for the quantitative determination of beta- amyloid (1-42) as an additional diagnostic tool in suspected clinical amyloid pathology of the brain.

EQ 6521-9601-LEQ 6521-9601

Total-Tau ELISATest kit for the quantitative determination of total tau for the diagnosis of neuronal apoptosis.

EQ 6531-9601-L

Phosphorylated-Tau ELISAP-tau (T181) determination is an additional diagnostic tool in suspected tauopathy in the brain of patients with neurodegenerative disorders.

Available Q3/2016

Beta-Amyloid Control SetCSF sample set with target values. Can be used for on-site training as well as regular internal quality con-trol of amyloid and tau measurements.

Available Q3/2016

ApoE4 ELISA

Test kit for ApoE4 protein determination. Measureable ApoE4 protein concentrations indicate at least one ApoE allele that is a risk factor for the develop ment of Alzheimer’s disease.

Available Q3/2016

Pan-ApoE ELISATest kit for the quantitative determination of pan-ApoE.

Available Q3/2016

BACE1 ELISATest kit for the determination of BACE1 protein con-centration.

Available Q3/2016

Neurogranin (trunc P75) ELISA

Test kit for the quantitative determination of neuro-granin.

Available Q3/2016

pNfH ELISA

Test for the quantitative determination of phosphory-lated neurofilament heavy chain. Can be used as an additional tool for the early diagnosis of motoneuro- nal diseases like amyotrophic lateral sclerosis.

Available Q3/2016

Available product Description Full blood sample Order no.

EUROArray APOE Direct

Test system for molecular genetic diagnostics of Alzheimer‘s disease and type III hyperlipoprotein emia, as well as other diseases associated with the allels ε2, ε3 and/or ε4 of the APOE gene.

MN 5710-0803-VMN 5710-0505-VMN 5710-1005-VMN 5710-2005-V

Antigen detection:

Molecular diagnostics:

HQ_1100_I_UK_A01, 06/2016